×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Clinical: A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M
clinical
2,198 words
KG: A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study ... (NCT04777331)
2026-03-28
kind:clinical-trial
section:clinical-trials
state:published
Contents
A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study ... (NCT04777331)
Knowledge Graph
Related Hypotheses (23)
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Purinergic Signaling Polarization Control
Score: 0.55
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
APOE Isoform Conversion Therapy
Score: 0.44
Optogenetic Control of Mitochondrial Transfer Networks
Score: 0.38
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Phase-Separated Organelle Targeting
Score: 0.52
Sleep Spindle-Synaptic Plasticity Enhancement
Score: 0.49
Stress Granule Phase Separation Modulators
Score: 0.49
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.44
Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics
Score: 0.42
Biorhythmic Interference via Controlled Sleep Oscillations
Score: 0.41
Extracellular Vesicle Biogenesis Modulation
Score: 0.34
Trans-Synaptic Adhesion Molecule Modulation
Score: 0.34
Show 18 more
Related Analyses (6)
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Show 1 more
Related Experiments (3)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
validation · proposed · Score: 0.40
See Also (15)
Neurodegeneration
disease · Pages share 8 hypotheses
A Phase 2 Double-Blind, Randomized, Placebo-Controlled
clinical · Pages share 8 hypotheses
vitamin-d-therapy-neurodegeneration
therapeutic · Pages share 7 hypotheses
TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 7 hypotheses
Trace Amine-Associated Receptor (TAAR) Modulator Therap
therapeutic · Pages share 7 hypotheses
SYK Kinase Inhibitor Therapy for Neurodegeneration
therapeutic · Pages share 7 hypotheses
STING Inhibitor Therapy in Neurodegeneration
therapeutic · Pages share 7 hypotheses
Specialized Pro-Resolving Mediator (SPM) Therapy for Ne
therapeutic · Pages share 7 hypotheses
Specialized Pro-Resolving Mediator (SPM) Therapies for
therapeutic · Pages share 7 hypotheses
Somatostatin Receptor Modulator Therapy in Neurodegener
therapeutic · Pages share 7 hypotheses
Section 152: Advanced Robotics and Assistive Devices in
therapeutic · Pages share 7 hypotheses
Section 147: Telehealth and Remote Monitoring in CBS/PS
therapeutic · Pages share 7 hypotheses
S100 Protein (S100A8/A9/A12) Modulator Therapy for Neur
therapeutic · Pages share 7 hypotheses
RNA Targeting Therapy for Neurodegeneration
therapeutic · Pages share 7 hypotheses
Progranulin Therapy for Neurodegeneration
therapeutic · Pages share 7 hypotheses
Show 10 more
Knowledge Graph (1 edges)
A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study ... (NCT04777331)
references
APOE